Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Margin

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Margin(%) 14.135.497.707.20-2.11

What is the latest EBIT Margin ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Margin ratio of SOTAC PHARMACEUTICALS is 14.13 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar202514.13
Mar20245.49
Mar20237.70
Mar20227.20
Mar2021-2.11

How is EBIT Margin of SOTAC PHARMACEUTICALS Trending?

Years EBIT Margin % Change
Mar2025 14.13
157.38
Mar2024 5.49
-28.70
Mar2023 7.7
6.94
Mar2022 7.2
Positive
Mar2021 -2.11 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Margin ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹123.2 Cr -10.6% -19.9% -5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,628.0 Cr 3.5% 5.6% 11.9% Stock Analytics
DIVIS LABORATORIES ₹167,975.0 Cr -1.3% 4.5% 16.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,804.0 Cr -0.7% 6.9% 47.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,829.0 Cr 1.3% 5.1% 17.5% Stock Analytics
CIPLA ₹106,768.0 Cr -1.9% -0.3% -6% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-10.6%

-19.9%

-5.7%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses